Results 251 to 260 of about 326,443 (336)
Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study
Momoko Tokura, Michiko Ando, Yuki Kojima, Rui Kitadai, Shu Yazaki, Cyrielle Marie N Atutubo, Rubi K. Li, Mia Perez, Agnes E Gorospe, Manuelito Madrid, Mel Valerie Cruz Ordinario, Marcelo Severino Bulauitan Imasa, Kazuki Sudo, Tatsunori Shimoi, Akihiko Suto, Shinji Kohsaka, Ryunosuke Machida, Ryo Sadachi, Masayuki Yoshida, Yasushi Yatabe, Tomomi Hata, Kenichi Nakamura, Kan Yonemori, Sho Shiino +23 moreopenalex +1 more sourceSonographic localisation of lymph nodes suspicious of metastatic breast cancer to surgical axillary levels
Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 119-138, March 2025.Sonographic imaging is used to identify the presence, number and location of malignant lymph nodes. Axillary lymph nodes suspicious of harbouring breast cancer metastasis can be localised to three surgical axillary levels. This paper will unpack the axillary anatomy, muscular sonographic landmarks, surgical axillary lymph node levels and the ...Michelle Fenech, Tracey Burke, Grace Arnett, Alisha Tanner, Natasha Werder +4 morewiley +1 more sourceHER2/CEP17 ratio is associated with pCR after HER2-directed neoadjuvant treatment in the phase III NeoALTTO trial. [PDF]
BreastSinger CF, Koenig F, Kacerovsky-Strobl S, Danzinger S, Brunner C, Suppan C, Deutschmann C, Balic M, Greil R, Egle D, de Azambuja E, Di Cosimo S, Choudhury A, Gnant M. +13 moreeuropepmc +1 more sourceDynamic Hematological Indicators Predict the Efficacy of Cdk4/6 Inhibitors in Hr-Positive, Her2-Negative Metastatic Breast Cancer: An Exploratory Analysis of the Bright-2 Trial
Hangcheng Xu, Yan Wang, Qiang Sa, Yiran Zhou, Fei Ma, Pin Zhang, Ying Fan, Ruigang Cai, Qiao Li, Bo Lan, Jiani Wang, Liang Cui, Xinxin Tan, Jing Bai, Yan Hu, Xianghui Duan, Fan Yang, Jiayu Wang, Binghe Xu +18 moreopenalex +1 more sourceChanging Practices in Axillary Surgery After Neoadjuvant Breast Cancer Therapy: Insights From the EUSOMA European Database
Journal of Surgical Oncology, EarlyView.ABSTRACT Introduction
Sentinel lymph node biopsy (SLNB) after neoadjuvant treatment (NAT) is an increasing option for axillary surgery in patients responding to treatment, whether diagnosed as clinically node‐negative (cN0) or node‐positive (cN + ). This study evaluates SLNB trends in patients with NAT in a large European population.Antonio J. Esgueva, Mariano Tomatis, Antonio Ponti, Lorenza Marotti, Maria Joao Cardoso, Kwok Leung Cheung, Jakob De Vries, Peter van Dam, Isabel T. Rubio, The Eusoma Working group, Chiara Annunziata Pasqualina Anghelone, Antonella Baldissera, Elisabetta Benozzi, Martine Berlière, Marina Bortul, Barbara Bussels, Francesco Caruso, Carla Cedolini, Fabio Corsi, Evelyn Despierre, Boudewijn Dullens, Gianluca Fogazzi, Lucio Fortunato, José Luis Fougo, Gianluca Frisoni, Daniele Generali, Alessandra Gennari, Matteo Ghilli, Marco Golinelli, Pedro Gouveia, Simona Grossi, Ruth Helfgott, Alessandra Huscher, Karolina F. Larsson, Sophie Marquette, Carmela Mocerino, Ida Negreiros, Francesca Pellini, Federico Piacentini, Romano Polato, Annemie Prové, Karol Rogowski, Giovanna Romanucci, Lorenzo Rossi, Claudia Francesca Rossi, Margherita Serra, Gracienne Staelens, Maud Vassilieff, Paolo Veronesi, Daniele Zanoni +49 morewiley +1 more sourceDisparities in Breast Cancer Screening, Diagnosis, and Outcomes Among Vietnamese American Women: A Systematic Review
Journal of Surgical Oncology, EarlyView.ABSTRACT
Breast cancer remains a leading cause of cancer‐related mortality among women globally. Vietnamese women experience unique challenges, including sociocultural, linguistic, and systemic barriers, contributing to disparities in screening utilization, late‐stage diagnoses, and treatment outcomes.Antoinette T. Nguyen, Emily D. Duckworth, Rena A. Li, Robert D. Galiano +3 morewiley +1 more sourceTranslational and real-world evidence of trastuzumab biosimilar CT-P6 plus pertuzumab in neoadjuvant HER2-positive early breast cancer. [PDF]
Breast Cancer Res TreatAlonso-Romero JL, Martínez-García J, Carrillo-Vicente R, Aramburo AF, Díez AF, Henarejos PS, de la Morena Barrio P, Boix AP, Jiménez MD, Siles JP, Maestre JAP, de Las Heras-Rubio A, Carreño PR. +12 moreeuropepmc +1 more source
